中基健康
(000972)
| 流通市值：23.22亿 | | | 总市值：23.22亿 |
| 流通股本：7.71亿 | | | 总股本：7.71亿 |
| 报告期 | 2024-09-30 | 2024-06-30 | 2024-03-31 | 2023-12-31 |
| 公司类型 | 通用 | 通用 | 通用 | 通用 |
| 一、营业总收入 | 297,820,015.92 | 245,129,564.67 | 119,254,852.12 | 575,779,449.91 |
| 营业收入 | 297,820,015.92 | 245,129,564.67 | 119,254,852.12 | 575,779,449.91 |
| 二、营业总成本 | 311,484,738.21 | 239,996,735.82 | 113,703,122.68 | 516,556,329.44 |
| 营业成本 | 256,221,131.28 | 202,697,047.06 | 97,085,570.65 | 430,214,558.24 |
| 税金及附加 | 2,189,000.8 | 2,073,432.56 | 88,350.97 | 6,295,336.71 |
| 销售费用 | 6,504,388.12 | 3,504,140 | 1,443,880.32 | 11,325,318.11 |
| 管理费用 | 22,702,853.62 | 17,495,352.14 | 9,342,827.73 | 48,695,585.84 |
| 研发费用 | 3,395,509.46 | 1,445,721.72 | 352,972.67 | 827,843.81 |
| 财务费用 | 20,471,854.93 | 12,781,042.34 | 5,389,520.34 | 19,197,686.73 |
| 其中:利息费用 | 20,612,683.28 | 14,008,872.56 | 6,335,081.78 | 22,023,665.98 |
| 其中:利息收入 | -178,249.21 | 154,428.09 | -82,722.5 | 1,909,870.46 |
| 资产处置收益 | 740,063.2 | 783,776.41 | 783,776.41 | 40,567,551.53 |
| 资产减值损失(新) | -30,656,410.28 | 885.01 | - | -206,443.89 |
| 信用减值损失(新) | 6,808,461.35 | 5,303,344.2 | -857,394.97 | -13,040,006.02 |
| 其他收益 | 3,057,352.04 | 1,364,733.3 | 859,834.1 | 2,072,561.48 |
| 营业利润平衡项目 | 0 | 0 | 0 | 0 |
| 四、营业利润 | -33,715,255.98 | 12,585,567.77 | 6,337,944.98 | 88,616,783.57 |
| 加:营业外收入 | 232,525.47 | 65,272.33 | 57,398.89 | 21,163,388.7 |
| 减:营业外支出 | 9,278,397.99 | 27,567.68 | 12,020.49 | 413,671.75 |
| 利润总额平衡项目 | 0 | 0 | 0 | 0 |
| 五、利润总额 | -42,761,128.5 | 12,623,272.42 | 6,383,323.38 | 109,366,500.52 |
| 减:所得税费用 | 152,423.18 | 299,411.54 | 203,556.59 | 219,125.81 |
| 六、净利润 | -42,913,551.68 | 12,323,860.88 | 6,179,766.79 | 109,147,374.71 |
| 持续经营净利润 | -42,913,551.68 | 12,323,860.88 | 6,179,766.79 | 109,147,374.71 |
| 归属于母公司股东的净利润 | -43,544,332.71 | 11,801,438.44 | 5,982,705.03 | 108,237,777.85 |
| 少数股东损益 | 630,781.03 | 522,422.44 | 197,061.76 | 909,596.86 |
| (一)基本每股收益 | -0.06 | 0.02 | 0.01 | 0.14 |
| (二)稀释每股收益 | -0.06 | 0.02 | 0.01 | 0.14 |
| 八、其他综合收益 | 4,738.79 | -24,258.56 | - | -112,470.26 |
| 归属于母公司股东的其他综合收益 | 4,738.79 | -24,258.56 | - | -112,470.26 |
| 九、综合收益总额 | -42,908,812.89 | 12,323,860.88 | 6,179,766.79 | 109,034,904.45 |
| 归属于母公司股东的综合收益总额 | -43,539,593.92 | 11,801,438.44 | 5,982,705.03 | 108,125,307.59 |
| 归属于少数股东的综合收益总额 | 630,781.03 | 522,422.44 | 197,061.76 | 909,596.86 |
| 公告日期 | 2024-10-26 | 2024-08-22 | 2024-04-25 | 2024-03-19 |
| 审计意见(境内) | | | | 标准无保留意见 |